ASCO: AstraZeneca Achieves Eye-Catching Solid Tumor Results With 'Armored' CAR-T

 
• By Andrew McConaghie

Solid tumor CAR-T may succeed AZD7003 where many others have failed as the firm builds its cell therapy pipeline.

McCormick Place
The ASCO conference was once again held at McCormick Place in Chicago. • Source: Shutterstock

More from Clinical Trials

More from R&D